MCL coexpression mm9:2132: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|ontology_enrichment_disease= | |ontology_enrichment_disease= | ||
|ontology_enrichment_uberon=UBERON:0002100!1.25e-08!90;UBERON:0005177!1.11e-07!79 | |ontology_enrichment_uberon=UBERON:0002100!1.25e-08!90;UBERON:0005177!1.11e-07!79 | ||
|tfbs_overrepresentation_for_novel_motifs=0.641384,0.402508,0.612053,0.688265,0.483253,0.704257,0.803568,0.370124,0.381467,0.489964,0.755749,0.790506,0.37041,0.81685,0.502646,0,1.02248,0.473993,0.352304,0.24402,0.570433,0.57409,0.815872,0.481455,0.620553,0.846564,0.342316,0.727368,0.535752,0.290745,0.711848,1.12823,0.471365,0.318879,0.503207,1.04375,0.460474,0.786577,0.434783,0.40068,0.478558,0.717547,0.185353,0.504971,0.0986756,0.675898,0.938241,0.744678,0.49007,0.539131,1.0041,0.875451,0.771943,1.2746,1.29252,0.82458,0.549352,0.776619,0.331485,0.822375,1.10737,0.885556,0.39557,0.992216,0.8366,1.03484,1.43193,1.78579,1.1025,1.63712,0.590754,0.377213,0.205546,1.32691,0.323563,0.834514,0.318792,0.926147,1.08947,0.575233,0.37865,1.04072,0.884013,0.951203,1.20828,0.11855,2.56445,0.290918,0.943446,1.94914,1.50286,1.21342,1.14153,0.490141,0.430015,0.409166,0.367176,1.14445,0.938512,0.264911,1.16494,1.12793,1.25667,1.00472,1.00361,0.717061,1.06633,0.740267,0.580757,0.57247,0.633483,1.25851,0.576517,0.7614,1.51002,0.476467,0.143825,0.692434,1.02384,0.456123,1.33244,0.970073,0.848526,0.925183,1.56496,1.09333,0.812403,1.13449,1.43038,0.493609,1.23918,0.680176,1.40022,0.839311,1.53196,1.08088,0.650785,0.719099,1.482,2.31884,1.91709,1.43673,0.861473,1.1391,0.996781,0.718046,0.941555,2.27909,0.653418,0.485304,0.79777,0.184289,1.27621,0.416214,0.838313,1.35996,0.87653,0.516549,1.54212,0.650472,1.49167,1.20739,1.09379,0.630949,0.993294,0.830321,0.459159,0.788782,0.0824127 | |||
}} | }} |
Revision as of 20:57, 26 November 2012
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr15:25870451..25870487,+ | p9@Fam134b |
Mm9::chr19:10020382..10020393,- | p@chr19:10020382..10020393 - |
Mm9::chr1:172989521..172989536,- | p2@Fcgr3 |
Mm9::chr4:149375404..149375413,- | p8@H6pd |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0047936 | glucose 1-dehydrogenase activity | 0.00701043274445327 |
GO:0019770 | IgG receptor activity | 0.00701043274445327 |
GO:0017057 | 6-phosphogluconolactonase activity | 0.00701043274445327 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 0.00701043274445327 |
GO:0001802 | type III hypersensitivity | 0.00701043274445327 |
GO:0001803 | regulation of type III hypersensitivity | 0.00701043274445327 |
GO:0004345 | glucose-6-phosphate dehydrogenase activity | 0.00701043274445327 |
GO:0001805 | positive regulation of type III hypersensitivity | 0.00701043274445327 |
GO:0001820 | serotonin secretion | 0.00701043274445327 |
GO:0019763 | immunoglobulin receptor activity | 0.00701043274445327 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 0.00701043274445327 |
GO:0001788 | antibody-dependent cellular cytotoxicity | 0.00701043274445327 |
GO:0019864 | IgG binding | 0.00701043274445327 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 0.00701043274445327 |
GO:0042533 | tumor necrosis factor biosynthetic process | 0.00701043274445327 |
GO:0001812 | positive regulation of type I hypersensitivity | 0.00701043274445327 |
GO:0006098 | pentose-phosphate shunt | 0.00701043274445327 |
GO:0001810 | regulation of type I hypersensitivity | 0.00701043274445327 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 0.00701043274445327 |
GO:0002894 | positive regulation of type II hypersensitivity | 0.00701043274445327 |
GO:0006740 | NADPH regeneration | 0.00701043274445327 |
GO:0001796 | regulation of type IIa hypersensitivity | 0.00701043274445327 |
GO:0002445 | type II hypersensitivity | 0.00701043274445327 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 0.00701043274445327 |
GO:0002888 | positive regulation of myeloid leukocyte mediated immunity | 0.00701043274445327 |
GO:0001794 | type IIa hypersensitivity | 0.00701043274445327 |
GO:0016068 | type I hypersensitivity | 0.00701043274445327 |
GO:0002892 | regulation of type II hypersensitivity | 0.00701043274445327 |
GO:0019865 | immunoglobulin binding | 0.00701043274445327 |
GO:0002675 | positive regulation of acute inflammatory response | 0.00701043274445327 |
GO:0002885 | positive regulation of hypersensitivity | 0.00701043274445327 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 0.00701043274445327 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 0.00701043274445327 |
GO:0002714 | positive regulation of B cell mediated immunity | 0.00701043274445327 |
GO:0006910 | phagocytosis, recognition | 0.00701043274445327 |
GO:0045576 | mast cell activation | 0.00701043274445327 |
GO:0002889 | regulation of immunoglobulin mediated immune response | 0.00701043274445327 |
GO:0002883 | regulation of hypersensitivity | 0.00701043274445327 |
GO:0002673 | regulation of acute inflammatory response | 0.00701043274445327 |
GO:0002712 | regulation of B cell mediated immunity | 0.00701043274445327 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 0.00701043274445327 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 0.00701043274445327 |
GO:0030593 | neutrophil chemotaxis | 0.00701043274445327 |
GO:0002524 | hypersensitivity | 0.00701043274445327 |
GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 0.00701043274445327 |
GO:0006739 | NADP metabolic process | 0.00743970612096549 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 0.00743970612096549 |
GO:0002437 | inflammatory response to antigenic stimulus | 0.00743970612096549 |
GO:0006911 | phagocytosis, engulfment | 0.00743970612096549 |
GO:0002705 | positive regulation of leukocyte mediated immunity | 0.00743970612096549 |
GO:0002444 | myeloid leukocyte mediated immunity | 0.00743970612096549 |
GO:0032640 | tumor necrosis factor production | 0.00743970612096549 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 0.00743970612096549 |
GO:0050766 | positive regulation of phagocytosis | 0.00744756424117877 |
GO:0050764 | regulation of phagocytosis | 0.00744756424117877 |
GO:0002699 | positive regulation of immune effector process | 0.00744756424117877 |
GO:0050729 | positive regulation of inflammatory response | 0.00744756424117877 |
GO:0002703 | regulation of leukocyte mediated immunity | 0.00744756424117877 |
GO:0031349 | positive regulation of defense response | 0.00744756424117877 |
GO:0002706 | regulation of lymphocyte mediated immunity | 0.00744756424117877 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.00750994298946373 |
GO:0002821 | positive regulation of adaptive immune response | 0.00750994298946373 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 0.00750994298946373 |
GO:0002697 | regulation of immune effector process | 0.00756662911250776 |
GO:0030595 | leukocyte chemotaxis | 0.00756662911250776 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 0.00756662911250776 |
GO:0045807 | positive regulation of endocytosis | 0.0080305863338368 |
GO:0001906 | cell killing | 0.0080305863338368 |
GO:0006769 | nicotinamide metabolic process | 0.0080305863338368 |
GO:0002819 | regulation of adaptive immune response | 0.0080305863338368 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. | 0.0080305863338368 |
GO:0001909 | leukocyte mediated cytotoxicity | 0.0080305863338368 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 0.00828037761672297 |
GO:0019362 | pyridine nucleotide metabolic process | 0.00852339831390692 |
GO:0002274 | myeloid leukocyte activation | 0.00946019410929288 |
GO:0031347 | regulation of defense response | 0.00989648583932346 |
GO:0050727 | regulation of inflammatory response | 0.00989648583932346 |
GO:0050900 | leukocyte migration | 0.0104428012558215 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 0.010509886011911 |
GO:0006733 | oxidoreduction coenzyme metabolic process | 0.010509886011911 |
GO:0051050 | positive regulation of transport | 0.0107042200392035 |
GO:0048002 | antigen processing and presentation of peptide antigen | 0.0107625460797819 |
GO:0030100 | regulation of endocytosis | 0.0107625460797819 |
GO:0006909 | phagocytosis | 0.0118842252695908 |
GO:0006767 | water-soluble vitamin metabolic process | 0.0120531437671891 |
GO:0045727 | positive regulation of translation | 0.0122181171744225 |
GO:0031328 | positive regulation of cellular biosynthetic process | 0.0129824368127697 |
GO:0008037 | cell recognition | 0.0129854729932073 |
GO:0048583 | regulation of response to stimulus | 0.0129854729932073 |
GO:0032403 | protein complex binding | 0.014298455035278 |
GO:0042035 | regulation of cytokine biosynthetic process | 0.0144295318923336 |
GO:0006007 | glucose catabolic process | 0.0146500853118655 |
GO:0009891 | positive regulation of biosynthetic process | 0.0146500853118655 |
GO:0046365 | monosaccharide catabolic process | 0.0146500853118655 |
GO:0019320 | hexose catabolic process | 0.0146500853118655 |
GO:0046164 | alcohol catabolic process | 0.0153168316673578 |
GO:0019882 | antigen processing and presentation | 0.0154291979758798 |
GO:0042089 | cytokine biosynthetic process | 0.0160742107120935 |
GO:0042107 | cytokine metabolic process | 0.0161765984876201 |
GO:0006766 | vitamin metabolic process | 0.0162769240998742 |
GO:0044275 | cellular carbohydrate catabolic process | 0.0171536103076992 |
GO:0016064 | immunoglobulin mediated immune response | 0.0179183655045773 |
GO:0019724 | B cell mediated immunity | 0.0179183655045773 |
GO:0051247 | positive regulation of protein metabolic process | 0.0179183655045773 |
GO:0016052 | carbohydrate catabolic process | 0.0179971882326395 |
GO:0002526 | acute inflammatory response | 0.0190628010616963 |
GO:0051049 | regulation of transport | 0.0205974710962379 |
GO:0003001 | generation of a signal involved in cell-cell signaling | 0.0211338254680621 |
GO:0002250 | adaptive immune response | 0.0212254100803507 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.0212254100803507 |
GO:0002449 | lymphocyte mediated immunity | 0.0217414165806211 |
GO:0050778 | positive regulation of immune response | 0.0223829177043655 |
GO:0006006 | glucose metabolic process | 0.0223829177043655 |
GO:0002684 | positive regulation of immune system process | 0.0223829177043655 |
GO:0002443 | leukocyte mediated immunity | 0.0223829177043655 |
GO:0001816 | cytokine production | 0.0223829177043655 |
GO:0042330 | taxis | 0.0228900631349165 |
GO:0006935 | chemotaxis | 0.0228900631349165 |
GO:0004091 | carboxylesterase activity | 0.0229174461935555 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 0.0240336476950901 |
GO:0050776 | regulation of immune response | 0.0240510436784332 |
GO:0002682 | regulation of immune system process | 0.0242823695583694 |
GO:0051240 | positive regulation of multicellular organismal process | 0.0249347756005532 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 0.025155104117616 |
GO:0006917 | induction of apoptosis | 0.0268175387162677 |
GO:0012502 | induction of programmed cell death | 0.0268175387162677 |
GO:0019318 | hexose metabolic process | 0.0268175387162677 |
GO:0006417 | regulation of translation | 0.0268175387162677 |
GO:0005996 | monosaccharide metabolic process | 0.0272082271734108 |
GO:0002252 | immune effector process | 0.0272082271734108 |
GO:0031326 | regulation of cellular biosynthetic process | 0.0277974889846219 |
GO:0005792 | microsome | 0.0303537488994884 |
GO:0009889 | regulation of biosynthetic process | 0.0305176438388193 |
GO:0042598 | vesicular fraction | 0.0306790495767813 |
GO:0006732 | coenzyme metabolic process | 0.0308380214289605 |
GO:0043065 | positive regulation of apoptosis | 0.0313779125208623 |
GO:0043068 | positive regulation of programmed cell death | 0.0315293362273279 |
GO:0010324 | membrane invagination | 0.0316380769624637 |
GO:0006897 | endocytosis | 0.0316380769624637 |
GO:0009117 | nucleotide metabolic process | 0.0338306805273247 |
GO:0051186 | cofactor metabolic process | 0.0346985195858322 |
GO:0055086 | nucleobase, nucleoside and nucleotide metabolic process | 0.0357370025259997 |
GO:0007626 | locomotory behavior | 0.0369423378237362 |
GO:0045321 | leukocyte activation | 0.0371501358980471 |
GO:0032940 | secretion by cell | 0.0371501358980471 |
GO:0006954 | inflammatory response | 0.0372518408134996 |
GO:0001775 | cell activation | 0.0392967491917958 |
GO:0044265 | cellular macromolecule catabolic process | 0.0397332974907156 |
GO:0051246 | regulation of protein metabolic process | 0.0403381072681309 |
GO:0016044 | membrane organization and biogenesis | 0.040588471108217 |
GO:0044262 | cellular carbohydrate metabolic process | 0.0428976130983566 |
GO:0006066 | alcohol metabolic process | 0.0436391866684175 |
GO:0046903 | secretion | 0.0442012902965828 |
GO:0016477 | cell migration | 0.0462701344748131 |
GO:0051239 | regulation of multicellular organismal process | 0.0468071282397463 |
GO:0009611 | response to wounding | 0.0481666997116998 |
GO:0009057 | macromolecule catabolic process | 0.0485192670346343 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
trunk | 1.25e-08 | 90 |
trunk region element | 1.11e-07 | 79 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |